Home » News » Dr. Sid Kerkar speaks with CGT Live about how EXUMA’s TaNK platforms aim to make CAR therapy safer and faster through novel lentivector engineering
CGT Live
Dr. Sid Kerkar speaks with CGT Live about how EXUMA’s TaNK platforms aim to make CAR therapy safer and faster through novel lentivector engineering
The Vice President of Research & Development, Oncology at Exuma Biotech discussed the company’s platforms, including CAR-TaNK cells.
